Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
Researchers at Lund University in Sweden have made a major breakthrough in diagnosing Lewy body disease, a leading cause of ...
Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's ...
While hearing loss has been associated with cognitive decline and considered a risk factor for dementia, this study, ...
Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...
Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...
C2N Wins $1.5M Grant From Michael J Fox Foundation to Study Links Between Neurodegenerative Diseases
The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.
Patients with ankylosing spondylitis are associated with an increased risk of developing neurodegenerative diseases, ...
Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback